SGS
CLB icon

Sterling Global Strategies’s Core Laboratories CLB Stock Holding History

Sterling Global Strategies’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-112
Closed -$6.68K – 58
2018
Q4 		$6.68K Buy
+112
New +$9.66K 0.03% 166

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sterling Global Strategies's CLB Position: Q1 2019 in Review

Sterling Global Strategies sold out of Core Laboratories (CLB) in Q1 2019, closing a stake of 112 shares — an estimated $6.68K sold.

Sterling Global Strategies first reported a position in CLB in Q4 2018 and held it in 1 quarter. The position peaked at $6.68K in Q4 2018. 313 funds tracked by Wall St. Rank hold CLB as of Q1 2019.

  • Sterling Global Strategies reported no remaining Core Laboratories position as of Q1 2019 after selling out during the quarter.
  • Sterling Global Strategies sold 112 Core Laboratories shares in Q1 2019, an estimated $6.68K.
  • Sterling Global Strategies first reported a position in Core Laboratories in Q4 2018 and held it in 1 quarter.
  • Sterling Global Strategies's Core Laboratories position peaked at $6.68K in Q4 2018.
  • 313 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2019.

Based on Sterling Global Strategies's 13F filing for Q1 2019, filed 15 May 2019.